The global topical scar treatment market is estimated to be USD 1.71 billion in 2024 and is expected to reach USD 5.91 billion by 2035, with a CAGR of 11.93% during the forecast period 2025-2035. The market will go up as a result of rising interest in aesthetic appearance, rising incidences of skin-related disorders and surgeries, improvements in product formulations, rising rates of burns and trauma injuries, and rising demand in emerging markets.
Ongoing research and development have resulted in innovative, user-friendly scar treatment formulations, such as quick-absorbing gels, water-resistant creams, and silicone-based sheets. For instance, in January 2023 launch of **Skinuva Scar+ SPF 30**, a physician-developed scar photoaging defense cream. Combining selective growth factors with mineral-based Zinc Oxide sunscreen, this clinically-tested solution not only improves scar appearance but also provides effective protection against photoaging, reflecting the industry's commitment to advancing science-backed skincare solutions.
By product, the creams segment accounted for the highest revenue-grossing segment in the global topical scar treatment market in 2024 owing to the widespread availability, ease of application, and effectiveness in reducing various types of scars, including surgical and acne scars. For instance, Skinuva proudly announced the release of its newest product, Skinuva Scar+ SPF 30, a dermatologist-developed cream that aims to redefine skincare standards, in January 2023. This scar photoaging defense cream, which combines highly selective growth factors with a mineral-based Zinc Oxide sunscreen to protect and improve scar look, was introduced by Skinuva, a company dedicated to developing skincare with scientifically supported, clinically verified formulas. Additionally, the silicon sheets segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing recognition of their proven efficacy in managing hypertrophic and keloid scars, coupled with their adoption in post-surgical care protocols.
By scar type, the atrophic scars segment accounted for the highest revenue-grossing segment in the global topical scar treatment market in 2024 owing to the high prevalence of acne-related atrophic scars and increased consumer demand for non-invasive treatment options. For instance, a February 2023 NIH report states that rates of hypertrophic scarring in adult burn victims range from 32% to 72% to be especially common. The following factors are linked to increased risks of hypertrophic scarring: burns that cover more than 20% of the body, particularly the neck and upper limbs; younger age; female gender; and darker skin tones. The thickness, color, vascularity, and hyperplasia of the scars frequently make neuropathic pain worse, as reported by nearly 75% of burn patients with hypertrophic scars. Additionally, the hypertrophic and keloid scar segment is predicted to grow at the fastest CAGR during the forecast period owing to its rising incidence due to surgical interventions and burn injuries, and advancements in targeted treatment formulations like silicone gels and pressure therapy products.
By distribution channel, the retail pharmacies segment accounted for the highest revenue-grossing segment in the global topical scar treatment market in 2024 owing to the ease of accessibility, trusted recommendations by healthcare professionals, and the wide range of products available. For instance, Dr. Speron's Natural Skin Care, LLC unveiled a cutting-edge product in September 2024 that is intended to significantly improve the physical and psychological effects of scars from wounds, surgeries, and skin disorders. Customers looking for safe, skin-friendly products with less synthetic chemicals will find these natural-based treatments appealing. Additionally, the online segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing popularity of e-commerce platforms, consumer preference for convenience, and availability of detailed product reviews and discounts.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high prevalence of surgical and acne-related scars, advanced healthcare infrastructure, strong consumer awareness regarding scar treatment options, and the presence of major market players offering innovative products. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to rising disposable incomes, increasing awareness of skincare solutions, a growing number of burn and trauma cases, and the rapid expansion of e-commerce platforms offering scar treatment products. For instance, Chulalongkorn University researchers created a novel "Transfersome Gel" in September 2024 to cure dark spots and hypertrophic scars. created using a crucial ingredient that comes from the Indian pennywort plant.
This comprehensive research report focuses on the global and regional market size and forecasts from 2024 to 2035.
Ongoing research and development have resulted in innovative, user-friendly scar treatment formulations, such as quick-absorbing gels, water-resistant creams, and silicone-based sheets. For instance, in January 2023 launch of **Skinuva Scar+ SPF 30**, a physician-developed scar photoaging defense cream. Combining selective growth factors with mineral-based Zinc Oxide sunscreen, this clinically-tested solution not only improves scar appearance but also provides effective protection against photoaging, reflecting the industry's commitment to advancing science-backed skincare solutions.
By product, the creams segment accounted for the highest revenue-grossing segment in the global topical scar treatment market in 2024 owing to the widespread availability, ease of application, and effectiveness in reducing various types of scars, including surgical and acne scars. For instance, Skinuva proudly announced the release of its newest product, Skinuva Scar+ SPF 30, a dermatologist-developed cream that aims to redefine skincare standards, in January 2023. This scar photoaging defense cream, which combines highly selective growth factors with a mineral-based Zinc Oxide sunscreen to protect and improve scar look, was introduced by Skinuva, a company dedicated to developing skincare with scientifically supported, clinically verified formulas. Additionally, the silicon sheets segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing recognition of their proven efficacy in managing hypertrophic and keloid scars, coupled with their adoption in post-surgical care protocols.
By scar type, the atrophic scars segment accounted for the highest revenue-grossing segment in the global topical scar treatment market in 2024 owing to the high prevalence of acne-related atrophic scars and increased consumer demand for non-invasive treatment options. For instance, a February 2023 NIH report states that rates of hypertrophic scarring in adult burn victims range from 32% to 72% to be especially common. The following factors are linked to increased risks of hypertrophic scarring: burns that cover more than 20% of the body, particularly the neck and upper limbs; younger age; female gender; and darker skin tones. The thickness, color, vascularity, and hyperplasia of the scars frequently make neuropathic pain worse, as reported by nearly 75% of burn patients with hypertrophic scars. Additionally, the hypertrophic and keloid scar segment is predicted to grow at the fastest CAGR during the forecast period owing to its rising incidence due to surgical interventions and burn injuries, and advancements in targeted treatment formulations like silicone gels and pressure therapy products.
By distribution channel, the retail pharmacies segment accounted for the highest revenue-grossing segment in the global topical scar treatment market in 2024 owing to the ease of accessibility, trusted recommendations by healthcare professionals, and the wide range of products available. For instance, Dr. Speron's Natural Skin Care, LLC unveiled a cutting-edge product in September 2024 that is intended to significantly improve the physical and psychological effects of scars from wounds, surgeries, and skin disorders. Customers looking for safe, skin-friendly products with less synthetic chemicals will find these natural-based treatments appealing. Additionally, the online segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing popularity of e-commerce platforms, consumer preference for convenience, and availability of detailed product reviews and discounts.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high prevalence of surgical and acne-related scars, advanced healthcare infrastructure, strong consumer awareness regarding scar treatment options, and the presence of major market players offering innovative products. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to rising disposable incomes, increasing awareness of skincare solutions, a growing number of burn and trauma cases, and the rapid expansion of e-commerce platforms offering scar treatment products. For instance, Chulalongkorn University researchers created a novel "Transfersome Gel" in September 2024 to cure dark spots and hypertrophic scars. created using a crucial ingredient that comes from the Indian pennywort plant.
This comprehensive research report focuses on the global and regional market size and forecasts from 2024 to 2035.
Report Scope:
- Base Year: 2024
- Forecast Period: 2025-2035
- Study Coverage
- Market Forecast by Product, Scar Type, and Distribution Channel
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Topical Scar Treatment Market Report 2024 - 2035
Topical Scar Treatment Market Analysis & Forecast by Product 2024 - 2035 (Revenue USD Bn)
- Creams
- Gels
- Silicon Sheets
- Others
Topical Scar Treatment Market Analysis & Forecast by Scar Type 2024 - 2035 (Revenue USD Bn)
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
Topical Scar Treatment Market Analysis & Forecast by Distribution Channel 2024 - 2035 (Revenue USD Bn)
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Hypermarkets/ Supermarkets
Topical Scar Treatment Market Analysis & Forecast by Region 2024 - 2035 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Topical Scar Treatment Market: Product Estimates & Trend Analysis
8. Topical Scar Treatment Market: Scar Type Estimates & Trend Analysis
9. Topical Scar Treatment Market: Distribution Channel Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Topical Scar Treatment Market
12. Europe Global Topical Scar Treatment Market
13. Asia Pacific Global Topical Scar Treatment Market
14. Latin America Global Topical Scar Treatment Market
15. MEA Global Topical Scar Treatment Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Smith & Nephew plc
- Mölnlycke Health Care AB
- Alliance Pharma PLC
- HRA Pharma (a Perrigo Company)
- Rejuvaskin (Scar Heal Inc.)
- SkinCeuticals (a division of L'Oréal)
- Merz Pharmaceuticals, LLC
- Sientra, Inc. (bioCorneum)
- Dermatix (Meda Pharmaceuticals, now part of Viatris)
- Perrigo Company plc
- Cicatricure (Genomma Lab)
- Biodermis
- Cimeosil (NuSil Technology)
- Stratpharma AG
- ScarAway
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 1.71 Billion |
| Forecasted Market Value ( USD | $ 5.91 Billion |
| Compound Annual Growth Rate | 11.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
